Cell Harvesting Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
The major factors driving the growth of the cell harvesting market include the increasing investment in regenerative medicine and cell-based research, growth of the biotechnology and biopharmaceutical industries, and increasing incidence of chronic and infectious diseases.
According to the World Health Organization (WHO), chronic diseases are expected to increase by 57%, by 2020. Increased demand for healthcare systems due to chronic diseases has become a major concern.
The Center for Disease Control and Prevention (CDC), stated that in 2017, chronic diseases were the leading cause of death and disability in the United States, and 133 million Americans, i.e., 45% of the population, had at least one chronic disease. Also, the rise of age and lifestyle-related chronic diseases is increasing the demand for and expenditure on healthcare.
In developing markets, cancer and heart disease are becoming the main causes of death, as a result of urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. The potential use of stem cells in treating various chronic diseases is the major factor for the growth of the market. Thus, the increasing prevalence of chronic and infectious diseases is expected to spur market growth.
Key Market TrendsStem Cell Research is Expected to be Fastest Growing SegmentThe market studied is a moderately consolidated market owing to the presence of the small and large market players. Some of the market players are Arthrex Inc., AVITA Medical, GE Healthcare, Pall Corporation, Perkin Elmer Inc., Sartorius AG, Terumo Corporation, and Tomtec
Additional Benefits:Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook